ARCH VENTURE PARTNERS
ARCH VENTURE MANAGEMENT LLC Legal Name
Adviser information for ARCH VENTURE PARTNERS last updated from Form ADV on March 28th, 2024. Select data displayed; additional Form ADV, Form D, Form 13F and other data is available from the Fincoded API.
Advisory Business
| Type of Organization | Limited Liability Company |
|---|---|
| Fiscal Year End | DECEMBER |
| Legal Location | Delaware, United States |
Employees
| Total Number of Employees | 0 |
|---|---|
| Investment Advisory/Research | 0 |
| Registered Broker-Dealer Representatives | 0 |
| Registered State Investment Advisers | 0 |
| Licensed Agents of an Insurance Company | 0 |
| No. of Firms/People that Solicit Clients | 0 |
RAUM
| Provides Management of Securities Portfolios | No |
|---|
Clients
| Type | Number | RAUM |
|---|---|---|
| Individuals | 0 | $0 |
| HNW Individuals | 0 | $0 |
| Banking or thrift institutions | 0 | $0 |
| Investment companies | 0 | $0 |
| Business development companies | 0 | $0 |
| Pooled investment vehicles | 0 | $0 |
| Pension and profit sharing plans | 0 | $0 |
| Charitable organizations | 0 | $0 |
| State or municipal gov entities | 0 | $0 |
| Other investment advisers | 0 | $0 |
| Insurance companies | 0 | $0 |
| Sovereign wealth funds and foreign official institutions | 0 | $0 |
| Corporations or other businesses | 0 | $0 |
| Other | 0 | $0 |
| Type | Number |
|---|---|
| No. of Non-RAUM Clients | 0 |
| No. of Non-U.S. Clients | 0 |
Services
| Advisory Services | – |
|---|---|
| Compensation | – |
Principal Office
8755 WEST HIGGINS ROADSUITE 1025
CHICAGO
IL
United States
Monday - Friday, 8AM-5PM
Tel: 773-380-6600, Fax: 773-380-6606
Websites
Chief Compliance Officer
NoneIndustry Affiliates
| ARCH VENTURE PARTNERS IX OVERAGE, LP | Sponsor, GP, manager of pooled investment vehicles |
| ARCH VENTURE PARTNERS IX, LP | Sponsor, GP, manager of pooled investment vehicles |
| ARCH VENTURE PARTNERS V, LP | Sponsor, GP, manager of pooled investment vehicles |
| ARCH VENTURE PARTNERS VI, LP | Sponsor, GP, manager of pooled investment vehicles |
| ARCH VENTURE PARTNERS VII, LP | Sponsor, GP, manager of pooled investment vehicles |
| ARCH VENTURE PARTNERS VIII LLC | Sponsor, GP, manager of pooled investment vehicles |
| ARCH VENTURE PARTNERS VIII, L.P. | Sponsor, GP, manager of pooled investment vehicles |
| ARCH VENTURE PARTNERS X OVERAGE, LP | Sponsor, GP, manager of pooled investment vehicles |
| ARCH VENTURE PARTNERS X, LP | Sponsor, GP, manager of pooled investment vehicles |
| ARCH VENTURE PARTNERS XI, LP | Sponsor, GP, manager of pooled investment vehicles |
| ARCH VENTURE PARTNERS XII, LP | Sponsor, GP, manager of pooled investment vehicles |
Private Funds
| Name | Type | Assets $USD | Min Investment $USD | No. Owners |
|---|---|---|---|---|
| ARCH V ENTREPRENEURS FUND LP | Venture Capital Fund | $0.3M | $0.0M | 30 |
| ARCH VENTURE FUND IX LP | Venture Capital Fund | $688.8M | $5.0M | 36 |
| ARCH VENTURE FUND IX OVERAGE LP | Venture Capital Fund | $515.2M | $5.0M | 31 |
| ARCH VENTURE FUND V LP | Venture Capital Fund | $30.6M | $1.0M | 57 |
| ARCH VENTURE FUND VI LP | Venture Capital Fund | $0.5M | $3.0M | 47 |
| ARCH VENTURE FUND VII LP | Venture Capital Fund | $150.6M | $3.0M | 39 |
| ARCH VENTURE FUND VIII LP | Venture Capital Fund | $405.4M | $3.0M | 22 |
| ARCH VENTURE FUND VIII OVERAGE LP | Venture Capital Fund | $203.0M | $5.0M | 5 |
| ARCH VENTURE FUND X LP | Venture Capital Fund | $1,535.5M | $5.0M | 76 |
| ARCH VENTURE FUND X OVERAGE LP | Venture Capital Fund | $1,570.0M | $5.0M | 75 |
| ARCH VENTURE FUND XI, LP | Venture Capital Fund | $2,396.7M | $5.0M | 100 |
| ARCH VENTURE FUND XII, LP | Venture Capital Fund | $3,082.2M | $5.0M | 109 |
| HEALTHCARE FOCUS FUND LP | Venture Capital Fund | $3.9M | $30.0M | 2 |
Control Persons
| Name | Type | Entity | Title | Since | Ownership |
|---|---|---|---|---|---|
| BYBEE, CLINTON, WHITEWOOD | Individual | – | MANAGING DIRECTOR | 09/2020 | < 5% |
| CRANDELL, KEITH, LAWRENCE | Individual | – | MANAGING DIRECTOR, PRESIDENT, SECRETARY AND SHAREHOLDER | 06/2001 | 25-50% |
| NELSEN, ROBERT, TAYLOR | Individual | – | MANAGING DIRECTOR, CEO, AND SHAREHOLDER | 06/2001 | 25-50% |
| BUROW, KRISTINA, MARIE | Individual | – | MANAGING DIRECTOR, VICE PRESIDENT, AND SHAREHOLDER | 09/2020 | 10-25% |
| MCDONNELL, MARK, ANDREW | Individual | – | MANAGING DIRECTOR, CFO AND CAO | 11/2011 | < 5% |
| GILLIS, STEVEN, NMN | Individual | – | MANAGING DIRECTOR | 10/2007 | < 5% |
No. Employees, Historic
Holdings
From latest 13F, filed August 14th, 2024 for period ending June 30th, 2024
| Name | Class | Value $USD | # Shares | Private Fund |
|---|---|---|---|---|
| UNITY BIOTECHNOLOGY, INC. | COM NEW | 1M | 1M | – |
| Q32 BIO INC. | COM | 6M | 320K | – |
| BEAM THERAPEUTICS INC. | COM | 128M | 5M | – |
| GOSSAMER BIO, INC. | COM | 7M | 8M | – |
| SINGULAR GENOMICS SYSTEMS, INC. | COM NEW | 1M | 127K | – |
| CERO THERAPEUTICS HOLDINGS, INC. | CLASS A COM | 432K | 1M | – |
| ERASCA, INC. | COM | 26M | 11M | – |
| VERVE THERAPEUTICS, INC. | COM | 10M | 2M | – |
| RAPPORT THERAPEUTICS, INC. | COM | 87M | 4M | – |